Risk of Toxicities with Immuno-TKI for Metastatic Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials

figure

posted on 2022-01-13, 11:05 authored by Alessandro Rizzo, Veronica Mollica, Matteo Santoni, Matteo Rosellini, Andrea Marchetti, Francesco Massari

Risk of Toxicities with Immuno-TKI for Metastatic Renal Cell Carcinoma: A Meta-analysis of Randomized Controlled Trials

History

Usage metrics

Categories

Keywords

immunotherapy safety immune checkpoint inhibitors tyrosine kinase inhibitors Renal Cell Carcinoma Cancer Therapy (excl. Chemotherapy and Radiation Therapy)Solid Tumours

Licence

CC BY-NC-ND 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC